The Chase Group Executive Search Logo
“Committed to Excellence in Life Sciences Executive Search”

Blog I

Biologics Consulting Partners with TCG to Build CMC Team

November 4, 2021
Biologics Consulting (BC) has an unprecedented record of achievement spanning almost three decades – a record of assisting clients to address nonclinical, clinical, product development,… Continue Reading →

TCG Retained to Identify Clinical Operations Leader

October 26, 2021
OncoQuest Pharma USA, Inc. has partnered with The Chase Group to identify a clinical operations leader for an opportunity to join its growing team. A… Continue Reading →

Atsena Therapeutics Process Development Opportunity

October 21, 2021
The Chase Group is pleased to announce their continued partnership with Atsena Therapeutics after being retained to execute a search for an Associate Director/Director of… Continue Reading →

Arcturus Retains TCG to Expand Vaccine Development Programs

October 19, 2021
As part of its growth strategy, Arcturus Therapeutics has partnered with The Chase Group to build and expand their vaccines development team. Founded in 2013… Continue Reading →

Biologics Consulting Cuts to the Chase for Regulatory Expertise

September 29, 2021
The Chase Group has been retained to find a highly motivated Regulatory Project Management professional with regulatory drug development experience in the pharmaceutical or biotech… Continue Reading →

Ionis VP Medical Affairs Successfully Placed by TCG

September 21, 2021
Ionis Pharmaceuticals has a 30-year track record of perfecting and advancing RNA-targeted drug discovery and development and is now expanding its commercialization capabilities. That expansion… Continue Reading →

High Expectations, Inspired By Patients and Fueled By Innovation

September 14, 2021
With a pipeline of more than 40 medicines, Ionis Pharmaceuticals is using its groundbreaking antisense therapies to bring better health and healing to millions of people. As clinical development and commercialization efforts continue to accelerate, Ionis works with The Chase Group to find leaders and executives who share a passion for helping patients, strive for excellence, and dare to dream big. Continue Reading →

The Chase Group Secures SVP, Regulatory for Atsena Therapeutics in Impressive Timeframe

September 8, 2021
After a comprehensive executive search that was completed in less than six weeks, The Chase Group is pleased to announce the placement of Dr. Molly… Continue Reading →

TCG Retained to Identify Vice President, Manufacturing/Supply Chain

September 3, 2021
Ventria Bioscience has partnered with The Chase Group to continue building its leadership team. The company’s technology is time-proven, with more than ten years of… Continue Reading →

Delivering Better Cancer Outcomes With the Best Teams

September 3, 2021
Checkmate Pharmaceuticals, a clinical stage immuno-oncology company, is focused on pioneering new medicines for combating melanoma, non-melanoma skin cancers, and head and neck cancer. Dr. James Wooldridge, Chief Medical Officer, has partnered with The Chase Group on executive search projects because of the thoroughness, productivity, and expert evaluations he receives from Chase as he builds out his clinical development and regulatory affairs teams at this fast-moving startup. Continue Reading →
© Copyright 1993-2022 The Chase Group; All Rights Reserved.